Citadel Advisors - MIRAGEN THERAPEUTICS INC ownership

MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 2 filers reported holding MIRAGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of MIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$128,000
+652.9%
165,127
+1002.4%
0.00%
Q2 2020$17,000
+70.0%
14,979
-32.2%
0.00%
Q1 2020$10,000
-82.5%
22,101
-20.4%
0.00%
Q2 2019$57,000
+3.6%
27,770
+51.1%
0.00%
Q4 2018$55,000
-3.5%
18,384
+79.5%
0.00%
Q3 2018$57,000
-51.3%
10,241
-38.6%
0.00%
Q1 2018$117,00016,6740.00%
Other shareholders
MIRAGEN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 3,142,580$2,451,0000.41%
Virtu Financial LLC 112,200$87,0000.02%
Seelaus Asset Management LLC 17,175$13,0000.01%
Aveo Capital Partners, LLC 16,732$13,0000.01%
Qube Research & Technologies Ltd 366,710$284,0000.00%
Banque Cantonale Vaudoise 50,000$39,0000.00%
GSA CAPITAL PARTNERS LLP 19,327$15,0000.00%
OneDigital Investment Advisors LLC 11,029$9,0000.00%
WELLS FARGO & COMPANY/MN 8,898$7,0000.00%
NORTHERN TRUST CORP 72,929$56,0000.00%
View complete list of MIRAGEN THERAPEUTICS INC shareholders